MGMT and glioblastoma: We have hereby devised a pharmacologic strategy for reactivating TUSC3 for reprogramming TMZ sensitivity in GBM, and we have demonstrated in vivo clinical translational feasibility with improved survival in MGMT-M and MGMT-UM GBM PDX mice models.